These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7187725)

  • 1. Diagnostic use of radioaerosols.
    Matthys H; Köhler D
    Arch Monaldi; 1982; 37(1-2):3-10. PubMed ID: 7187725
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug therapy of bronchosecretolytic disorders].
    Schmidt OP
    Med Klin; 1977 Feb; 72(5):145-60. PubMed ID: 321928
    [No Abstract]   [Full Text] [Related]  

  • 3. Theory and practice of the use of expectorants reviewed from clinical aspects.
    Nagy G
    Ther Hung; 1984; 32(1):6-12. PubMed ID: 6400475
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experience with a new mucus disolving agent (Bisolvon) for the therapy of whooping cough and diseases of the respiratory tract].
    Ertogan F
    Kinderarztl Prax; 1967 Apr; 35(4):141-6. PubMed ID: 5594869
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experience with a combination of auxiloson and bisolvon is diseases of the respiratory tract following multilocular findings].
    Mertens H
    Z Allgemeinmed; 1969 Sep; 45(26):1222-5. PubMed ID: 5374621
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mucolytic and mucoregulatory agents].
    Yernault JC
    Rev Med Brux; 1987 Oct; 8(8):423. PubMed ID: 3423520
    [No Abstract]   [Full Text] [Related]  

  • 7. The pharmacologic approach to airway clearance: mucoactive agents.
    Rubin BK
    Paediatr Respir Rev; 2006; 7 Suppl 1():S215-9. PubMed ID: 16798570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical aerosols. I. Characterization of aerosols and their diagnostic uses.
    Lourenço RV; Cotromanes E
    Arch Intern Med; 1982 Nov; 142(12):2163-72. PubMed ID: 6753780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mobilization and examination of respiratory secretions for the diagnosis and treatment of chest diseases.
    Cohen BM
    J Maine Med Assoc; 1970 Apr; 61(4):69-75. PubMed ID: 4913511
    [No Abstract]   [Full Text] [Related]  

  • 10. [Inhalation therapy of the upper respiratory tract].
    Hartl W
    HNO; 1973 Feb; 21(2):33-9. PubMed ID: 4571601
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mucolytics in acute and chronic respiratory tract disorders. I. Pathophysiology and mechanisms of action].
    Kupczyk M; Kuna P
    Pol Merkur Lekarski; 2002 Mar; 12(69):245-7. PubMed ID: 12053600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Modifiers of bronchial secretions in the asthmatic patient].
    Medici TC; Radielovic P
    Allergol Immunopathol (Madr); 1981; Suppl 9():201-6. PubMed ID: 7349729
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical evaluation of ascoxal a new mucolytic agent.
    Fisher AJ; Ten Pas RH
    Anesth Analg; 1966; 45(5):531-4. PubMed ID: 5330913
    [No Abstract]   [Full Text] [Related]  

  • 14. [Expectorants in the therapy of respiratory disease].
    Ther Umsch; 1965 Jul; 22(7):392-402. PubMed ID: 5834882
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of mucociliary clearance by means of bronchofibroscopy].
    Blasi A; Olivieri D
    Arch Monaldi; 1982; 37(1-2):27-36. PubMed ID: 7187724
    [No Abstract]   [Full Text] [Related]  

  • 16. [Aerosols in medicine].
    Pickroth G
    Z Erkr Atmungsorgane Folia Bronchol; 1970; 132(3):355-66. PubMed ID: 4923628
    [No Abstract]   [Full Text] [Related]  

  • 17. [Parenteral treatment of respiratory tract diseases with Bisolvone].
    Stahlmann W; Siehoff F; Mathey HG; Schilling T; Weis H
    Dtsch Med J; 1966 Aug; 17(16):478-80. PubMed ID: 5925468
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical evaluation of new therapies for treatment of mucus hypersecretion in respiratory diseases.
    Disse B
    Novartis Found Symp; 2002; 248():254-72; discussion 272-6, 277-82. PubMed ID: 12568499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mucolytics in acute and chronic respiratory tract disorders. II. Uses for treatment and antioxidant properties].
    Kupczyk M; Kuna P
    Pol Merkur Lekarski; 2002 Mar; 12(69):248-52. PubMed ID: 12053601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of affections of the respiratory organs in heart diseases using Bisolvon and Auxiloson in a dose inhaler].
    Guttmann W
    Hippokrates; 1968 Feb; 39(4):147-9. PubMed ID: 5712074
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.